Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Microvision Q1 Loss Widens - Quick Facts

Microvision Inc. (MVIS: Quote) reported that its first-quarter net loss was $9.8 million, or $0.58 per share, compared to a loss $9.0 million, or $0.70 per share for the same quarter a year ago.

Revenue was $1.7 million, compared to $1.1 million a year ago, primarily from the sale of current generation PicoP display engines and the SHOWWX family of pico projectors.

Analysts polled by Thomson Reuters expected the company to report a loss of $0.50 per share on revenues of $1.27 million for the quarter. Analysts' estimates typically exclude special items.

MicroVision said it plans to reduce its cash used in operations by approximately 50% during the second half of 2012 to align to its "Image by PicoP" ingredient brand model.

Click here to receive FREE breaking news email alerts for Microvision Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Stocks moved notably higher over the course of the trading day on Friday after initially showing a lack of direction. The gains on the day extended the recent upward trend by the markets, with the tech-heavy Nasdaq reaching its best closing level in almost a month. Looking to capitalize on news of an Ebola diagnosis in New York City, Republican Senate candidate Scott Brown issued a statement Friday criticizing his Democratic opponent Sen. Jeanne Shaheen, D-N.H., for "waffling" on a travel ban. In another troubling sign for Democrats, the results of a Gallup poll released on Friday show that Tea Party Republicans are much more motivated to vote in the upcoming midterm elections than other Americans. The poll found that 73 percent of Tea Party Republicans are "extremely" or "very" motivated to vote in this year's elections.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.